Qualigen Therapeutics, Inc. (QLGN)
NASDAQ: QLGN · Real-Time Price · USD
3.900
-0.060 (-1.52%)
Dec 20, 2024, 4:00 PM EST - Market closed
Qualigen Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2020 |
| Dec '24 Dec 20, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Mar '20 Mar 31, 2020 |
| Market Capitalization | 3 | 3 | 5 | 38 | 80 | - | |
| Market Cap Growth | -9.71% | -47.50% | -85.62% | -53.03% | - | - | |
| Enterprise Value | 4 | 2 | 5 | 26 | 67 | - | |
| Last Close Price | 3.90 | 27.50 | 64.45 | 535.00 | 1505.00 | - | |
| PS Ratio | - | - | - | 6.68 | 18.67 | - | |
| PB Ratio | -2.15 | -1.35 | 0.62 | 2.28 | 4.39 | - | |
| P/TBV Ratio | - | - | 0.75 | 2.30 | 4.44 | - | |
| EV/Sales Ratio | - | - | - | 4.55 | 15.66 | - | |
| Debt / Equity Ratio | -0.67 | -0.62 | 0.01 | 0.10 | 0.03 | -1.15 | |
| Debt / FCF Ratio | - | - | - | - | - | 44.07 | |
| Asset Turnover | - | - | - | 0.22 | - | 1.45 | |
| Inventory Turnover | - | - | - | 15.97 | - | 7.36 | |
| Quick Ratio | 0.38 | 0.10 | 0.37 | 3.96 | 2.36 | 0.16 | |
| Current Ratio | 0.52 | 0.28 | 1.26 | 4.49 | 2.71 | 0.30 | |
| Return on Equity (ROE) | - | -374.45% | -109.70% | -102.68% | - | - | |
| Return on Assets (ROA) | -126.39% | -66.92% | -44.02% | -54.52% | - | -24.45% | |
| Return on Capital (ROIC) | - | -176.14% | -68.16% | -76.22% | - | -86.34% | |
| Earnings Yield | -276.50% | -470.85% | -343.44% | -47.40% | -25.40% | - | |
| FCF Yield | -338.76% | -361.61% | -244.08% | -39.37% | -12.40% | - | |
| Buyback Yield / Dilution | -98.44% | -32.09% | -30.91% | -102.67% | -158.37% | - | |
| Total Shareholder Return | -98.44% | -32.09% | -30.91% | -102.67% | -158.37% | - | |
Source: S&P Capital IQ. Standard template.
Financial Sources.